Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
08/29/2025 | CALL | $48.00 | 3,239 | +2,003 | +162.06% |
10/17/2025 | CALL | $52.50 | 3,607 | +1,456 | +67.69% |
09/05/2025 | CALL | $49.00 | 2,853 | +655 | +29.80% |
10/17/2025 | CALL | $49.00 | 1,343 | +641 | +91.31% |
11/21/2025 | CALL | $50.00 | 5,008 | +214 | +4.46% |
09/19/2025 | CALL | $44.00 | 705 | +189 | +36.63% |
08/29/2025 | PUT | $50.00 | 7 | -29 | -80.56% |
11/21/2025 | PUT | $45.00 | 3,327 | -32 | -0.95% |
09/12/2025 | PUT | $47.00 | 138 | -40 | -22.47% |
11/21/2025 | PUT | $40.00 | 4,524 | -42 | -0.92% |
01/16/2026 | CALL | $43.00 | 7,059 | -49 | -0.69% |
12/19/2025 | CALL | $57.50 | 1,922 | -200 | -9.43% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.07% | 64.63M | 4.03B |
Vanguard 500 Index Fund | 2.34% | 49.15M | 3.06B |
Fidelity 500 Index Fund | 1.11% | 23.31M | 1.45B |
SPDR S&P 500 ETF Trust | 1.09% | 23.02M | 1.43B |
iShares Core S&P 500 ETF | 0.90% | 18.98M | 1.18B |
Vanguard Index-Value Index Fund | 0.87% | 18.37M | 1.14B |
JP Morgan Equity Income Fund | 0.82% | 17.35M | 1.08B |
Select Sector SPDR Fund-Health Care | 0.82% | 17.27M | 1.08B |
American Mutual Fund Inc | 0.78% | 16.49M | 1.03B |
Vanguard Institutional Index Fund-Institutional Index Fund | 0.71% | 14.9M | 927.91M |
Hodgkin’s Lymphoma Market Set to Reach New Heights by 2034 with Innovative Therapies and Clinical Successes | DelveInsight
08/28 01:00 pm
GlobeNewswire Inc.
Read moreScenic Enters License and Research Agreement with Alnylam
08/26 05:00 am
GlobeNewswire Inc.
Read moreAnal Cancer Market Size to Reach USD 2.08 Billion by 2032, Fueled by Rising HPV-Linked Cases and Advancements in Targeted Therapies – SNS Insider
08/22 10:00 am
GlobeNewswire Inc.
Read moreQuestex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing
08/20 10:00 am
GlobeNewswire Inc.
Read morePD-(L)1 Inhibitors Market Set to Surge During the Forecast Period (2025–2034) as Immuno-Oncology Therapies Gain Momentum | DelveInsight
08/18 01:00 pm
GlobeNewswire Inc.
Read moreWant Over $2,100 in Annual Dividends? Invest $12,000 Into Each of These 3 High-Yielding Stocks
08/13 06:26 am
The Motley Fool
Read moreCytomX (CTMX) Q2 Revenue Drops 26%
08/07 06:29 pm
The Motley Fool
Read morePRME Revenue Misses by 73%
08/07 12:27 pm
The Motley Fool
Read moreGlobal Myeloproliferative Disorder Treatment Market is Expected to Showcase an Incremental Growth at a CAGR of ~5% by 2032 | DelveInsight
08/06 01:00 pm
GlobeNewswire Inc.
Read moreBioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth
08/04 10:32 am
Benzinga
Read moreTesticular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer
08/01 04:51 am
GlobeNewswire Inc.
Read moreAdrenocortical Carcinoma Market Forecast upto 2034—Insights into Emerging Therapies and Market Trends | DelveInsight
07/29 01:00 pm
GlobeNewswire Inc.
Read moreAltanine Names Charles J. Andres, Ph.D., J.D., as CEO to Lead Clinical and Strategic Expansion
07/29 10:00 am
GlobeNewswire Inc.
Read moreOncology Drugs Market Insights, Competitive Landscape, and Forecast Report 2025-2032 | Immunotherapy Leads Growth in Oncology Market Due to Better Precision and Fewer Side Effects
07/25 10:50 am
GlobeNewswire Inc.
Read moreRheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports
07/23 12:51 pm
GlobeNewswire Inc.
Read moreMelanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight
07/22 01:00 pm
GlobeNewswire Inc.
Read moreBristol Myers' Drug Flunks Blood Cancer-Associated Anemia Trial
07/18 01:54 pm
Benzinga
Read moreAs Excitement Builds for HR Tech 2025, HR Executive Reveals Finalists of HR Icons Awards
07/16 07:00 am
GlobeNewswire Inc.
Read more3 Reasons the Schwab U.S. Dividend Equity ETF Is an Attractive Investment for Retirees
07/16 04:25 am
The Motley Fool
Read moreFDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers
06/27 11:34 am
Benzinga
Read more2 Beaten-Down Stocks to Avoid
06/27 08:15 am
The Motley Fool
Read moreMultiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight
06/24 01:00 pm
GlobeNewswire Inc.
Read moreICPO Foundation ist Co-Founder der RLT Angels Association mit dem Ziel, den Zugang zur Radiotheranostik für eine Million PatientInnen auszubauen
06/21 06:20 am
GlobeNewswire Inc.
Read moreICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients
06/21 06:20 am
GlobeNewswire Inc.
Read moreEditas Medicine Is Great. Here's Why You Shouldn't Buy It.
06/17 10:07 am
The Motley Fool
Read more2 Beaten-Down Dividend Stocks to Buy Right Now
06/16 04:25 am
The Motley Fool
Read morePhilochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties
06/10 05:55 pm
GlobeNewswire Inc.
Read moreRheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies
06/10 04:53 am
GlobeNewswire Inc.
Read moreDilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight
06/05 01:00 pm
GlobeNewswire Inc.
Read moreEpigenetics Market Anticipated to Achieve 11.8% CAGR
06/03 01:31 pm
GlobeNewswire Inc.
Read moreBristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug
06/02 10:14 am
Benzinga
Read moreBispecific Antibody Drug Conjugates Clinical Trials Bispecific ADC Market Size Insight
05/29 01:16 pm
GlobeNewswire Inc.
Read moreRapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors
05/27 09:00 am
GlobeNewswire Inc.
Read moreGlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases
05/27 07:00 am
GlobeNewswire Inc.
Read moreTubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic
05/20 05:00 am
GlobeNewswire Inc.
Read moreBlood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight
05/12 01:00 pm
GlobeNewswire Inc.
Read moreU.S. Small Business Association Awards Renaissance Global Services Two Prestigious Honors
05/09 07:00 am
GlobeNewswire Inc.
Read moreFDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight
05/06 03:21 pm
Benzinga
Read moreFDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months
05/02 03:37 pm
Benzinga
Read moreThis High-Yield Pharma Stock Looks Like an Incredible Bargain
04/30 06:45 am
The Motley Fool
Read moreAnalysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - Merck, Roche, Bristol-Myers Squibb Company, Johnson & Johnson Services, and AstraZeneca Dominate
04/30 04:56 am
GlobeNewswire Inc.
Read more4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
04/26 06:05 pm
The Motley Fool
Read moreBristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact
04/24 11:55 am
Benzinga
Read moreThermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll
04/23 04:49 pm
Benzinga
Read moreIs High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill?
04/15 07:39 am
The Motley Fool
Read moreThese Large-Cap Stocks With China And EU Exposure Got Crushed In The One Of The Most Volatile Trading Week (Apr 7-Apr 11): Are These In Your Portfolio?
04/13 11:33 am
Benzinga
Read moreSpecialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights
04/10 01:58 pm
GlobeNewswire Inc.
Read moreBiopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline
04/10 05:59 am
GlobeNewswire Inc.
Read moreIs Vertex Pharmaceuticals Stock a Buy?
04/08 09:45 am
The Motley Fool
Read moreMinimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide
04/08 04:48 am
GlobeNewswire Inc.
Read more